packageCertolizumabPegol

certolizumab pegol

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Certolizumab pegol is a TNF-alpha inhibitor used to treat inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. It is an approved medicine, authorised in the European Union, and is also being investigated for further uses.

Summary written by glm-5.3-flash from Wikidata Q412909 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:certolizumab pegol
ATC codes:L04AB05
DrugBank:DB08904
Wikidata:Q412909
molar mass:91000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown